These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 29889862)
61. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial. Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E; Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227 [TBL] [Abstract][Full Text] [Related]
62. Quantification and factors associated with HIV-related stigma among persons living with HIV/AIDS on antiretroviral therapy at the HIV-day care unit of the Bamenda Regional Hospital, North West Region of Cameroon. Ajong AB; Njotang PN; Nghoniji NE; Essi MJ; Yakum MN; Agbor VN; Kenfack B Global Health; 2018 Jun; 14(1):56. PubMed ID: 29866206 [TBL] [Abstract][Full Text] [Related]
63. Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration. Ekouévi DK; Avettand-Fènoël V; Tchounga BK; Coffie PA; Sawadogo A; Minta D; Minga A; Eholie SP; Plantier JC; Damond F; Dabis F; Rouzioux C; PLoS One; 2015; 10(6):e0129886. PubMed ID: 26111242 [TBL] [Abstract][Full Text] [Related]
64. The Treatment Cascade in Children With Unsuppressed Viral Load-A Reality Check in Rural Lesotho, Southern Africa. Lejone TI; Ringera I; Cheleboi M; Wagner S; Muhairwe J; Klimkait T; Labhardt ND J Acquir Immune Defic Syndr; 2018 Mar; 77(3):250-256. PubMed ID: 29189416 [TBL] [Abstract][Full Text] [Related]
65. Increasing multimonth dispensing of antiretrovirals and assessing the effect on viral load suppression among children and adolescents receiving HIV services in Nigeria. Casalini C; Bateganya M; Akolo C; Sanwo O; Idemudia A; Nwaokoro P; Eyam F; Ogbechie MD; Obiora-Okafo C; Oduola A; Wilcher R; Mack N; Khamofu H; Pandey SR PLoS One; 2023; 18(6):e0286303. PubMed ID: 37315075 [TBL] [Abstract][Full Text] [Related]
66. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients. Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I; HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742 [TBL] [Abstract][Full Text] [Related]
67. Early clinical experience of dolutegravir in an HIV cohort in a larger teaching hospital. Todd S; Rafferty P; Walker E; Hunter M; Dinsmore WW; Donnelly CM; McCarty EJ; Quah SP; Emerson CR Int J STD AIDS; 2017 Oct; 28(11):1074-1081. PubMed ID: 28118801 [TBL] [Abstract][Full Text] [Related]
68. Discordance of Self-report and Laboratory Measures of HIV Viral Load Among Young Men Who Have Sex with Men and Transgender Women in Chicago: Implications for Epidemiology, Care, and Prevention. Mustanski B; Ryan DT; Remble TA; D'Aquila RT; Newcomb ME; Morgan E AIDS Behav; 2018 Jul; 22(7):2360-2367. PubMed ID: 29637386 [TBL] [Abstract][Full Text] [Related]
69. Low HIV viral suppression rates following the intensive adherence counseling (IAC) program for children and adolescents with viral failure in public health facilities in Uganda. Nasuuna E; Kigozi J; Babirye L; Muganzi A; Sewankambo NK; Nakanjako D BMC Public Health; 2018 Aug; 18(1):1048. PubMed ID: 30134880 [TBL] [Abstract][Full Text] [Related]
70. Outcomes of second-line combination antiretroviral therapy for HIV-infected patients: a cohort study from Rio de Janeiro, Brazil. Cardoso SW; Luz PM; Velasque L; Torres TS; Tavares IC; Ribeiro SR; Moreira RI; Veloso VG; Moore RD; Grinsztejn B BMC Infect Dis; 2014 Dec; 14():699. PubMed ID: 25523385 [TBL] [Abstract][Full Text] [Related]
71. Two-year outcome of first-line antiretroviral therapy among HIV-1 vertically-infected children in Hanoi, Vietnam. Pham HV; Ishizaki A; Nguyen LV; Phan CT; Phung TT; Takemoto K; Pham AN; Bi X; Khu DT; Ichimura H Int J STD AIDS; 2015 Oct; 26(11):821-30. PubMed ID: 25332224 [TBL] [Abstract][Full Text] [Related]
72. Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon . Zoufaly A; Jochum J; Hammerl R; Nassimi N; Raymond Y; Burchard GD; Schmiedel S; Drexler JF; Campbell NK; Taka N; Awasom C; Metzner KJ; van Lunzen J; Feldt T J Antimicrob Chemother; 2015 Mar; 70(3):922-5. PubMed ID: 25428920 [TBL] [Abstract][Full Text] [Related]
73. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy. Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288 [TBL] [Abstract][Full Text] [Related]
74. Viral load scale-up in south Sudan: Strategic implementation of tools to monitor HIV treatment success among people living with HIV. Chun H; Russell A; Abe G; Katoro J; Songok J; Lesuk G; Worku H; Ukaejiofo O; Lodiongo D; Olemukun R; Kenigsberg T; Aragaw S; Deng LL; Bunga S; Ellenberger D Int J STD AIDS; 2022 Jul; 33(8):784-791. PubMed ID: 35618534 [TBL] [Abstract][Full Text] [Related]
75. On the front line of HIV virological monitoring: barriers and facilitators from a provider perspective in resource-limited settings. Rutstein SE; Golin CE; Wheeler SB; Kamwendo D; Hosseinipour MC; Weinberger M; Miller WC; Biddle AK; Soko A; Mkandawire M; Mwenda R; Sarr A; Gupta S; Mataya R AIDS Care; 2016; 28(1):1-10. PubMed ID: 26278724 [TBL] [Abstract][Full Text] [Related]
76. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic. Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P Glob Health Action; 2016; 9():29943. PubMed ID: 26765104 [TBL] [Abstract][Full Text] [Related]
77. Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. Lampe FC; Gatell JM; Staszewski S; Johnson MA; Pradier C; Gill MJ; de Lazzari E; Dauer B; Youle M; Fontas E; Krentz HB; Phillips AN Arch Intern Med; 2006 Mar; 166(5):521-8. PubMed ID: 16534038 [TBL] [Abstract][Full Text] [Related]
78. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients. Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468 [TBL] [Abstract][Full Text] [Related]
79. First-line antiretroviral therapy durability in a 10-year cohort of naïve adults started on treatment in Uganda. Castelnuovo B; Kiragga A; Mubiru F; Kambugu A; Kamya M; Reynolds SJ J Int AIDS Soc; 2016; 19(1):20773. PubMed ID: 27319742 [TBL] [Abstract][Full Text] [Related]
80. Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study. Court R; Leisegang R; Stewart A; Sunpath H; Murphy R; Winternheimer P; Ally M; Maartens G BMC Infect Dis; 2014 Dec; 14():664. PubMed ID: 25472544 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]